Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.50 |
| ▸ | DUT | P33316 | 9/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | CRBN | Q96SW2 | 1/20 | 0.42 |
| ▸ | THRB | P10828 | 1/20 | 0.42 |
| ▸ | NAAA | Q02083 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 2/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
| ▸ | TP53 | P04637 | 1/20 | 0.41 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24205027 | 0.91 | DUT (0.52) | L3MBTL1DUTALDH1A1NAAATSHR | |
| SCHEMBL26034675 | 0.89 | ALDH1A1 (0.44) | L3MBTL1DUTALDH1A1LMNATHRB | |
| SCHEMBL25368913 | 0.89 | ALDH1A1 (0.51) | L3MBTL1DUTALDH1A1NAAATSHR | |
| SCHEMBL24205030 | 0.89 | ALDH1A1 (0.51) | L3MBTL1DUTALDH1A1NAAATSHR | |
| SCHEMBL26035014 | 0.89 | ALDH1A1 (0.51) | L3MBTL1DUTALDH1A1NAAATSHR | |
| SCHEMBL24205029 | 0.89 | ALDH1A1 (0.51) | L3MBTL1DUTALDH1A1NAAATSHR | |
| SCHEMBL26035032 | 0.89 | ALDH1A1 (0.51) | L3MBTL1DUTALDH1A1NAAATSHR | |
| SCHEMBL6537409 | 0.83 | L3MBTL1 (0.54) | L3MBTL1DUTALDH1A1LMNACRBN | |
| SCHEMBL25623162 | 0.82 | L3MBTL1 (0.48) | L3MBTL1DUTALDH1A1LMNACRBN | |
| SCHEMBL16092911 | 0.81 | DUT (0.49) | L3MBTL1DUTALDH1A1LMNACRBN |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-57089751-A | — | — | None | — | — | JP | disclosed |
| US-20230273455-A1 | OPTICALLY ACTIVE DEVICES | JOHNSON & JOHNSON SURGICAL VISION INC (US) | 2023-08-31 | — | — | US | disclosed |
| US-20220107576-A1 | RESIN COMPOSITION, TONER FOR DEVELOPING ELECTROSTATIC CHARGE IMAGE, IMAGE FORMING METHOD, PHOTOSENSITIVE ADHESIVE, AND OPTICAL SWITCHING MATERIAL | Konica Minolta, Inc. (JP) | 2022-04-07 | — | — | US | disclosed |
| WO-2022012798-A1 | OPTICALLY ACTIVE DEVICES | MERCK PATENT GMBH (DE) | 2022-01-20 | — | — | WO | disclosed |
| JP-S5789751-A | PHOTOSENSITIVE MATERIAL | JAPAN SYNTHETIC RUBBER CO LTD | 1982-06-04 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230273455-A1 | OPTICALLY ACTIVE DEVICES | PDE6C, PDE6A, PDE6D | L3MBTL1 4743/4885DUT 1356/4885ALDH1A1 311/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.